Dynavax Technologies · 2 months ago
Director, Drug Substance, Process Development & Manufacturing Sciences
Dynavax Technologies is a commercial-stage biopharmaceutical company developing novel vaccines. The Director of Drug Substance, Process Development & Manufacturing Sciences will oversee CMC initiatives, manage technical operations, and collaborate with various teams to ensure successful project execution.
BiopharmaBiotechnologyClinical TrialsHealth CareMedical Device
Responsibilities
Lead drug substance process development, scale-up and/or technical transfer projects from initiation through regulatory approval; including the creation of development and/or technical transfer plans
Provide CMC oversight as it relates to project planning and execution, and on-going operations of assigned projects at CROs, CDMOs, etc
Significant cross functional collaboration with Quality, Quality Control, Analytical Development, Manufacturing, MS&T, Clinical and Regulatory functions
Provide CMC sections for regulatory filings (INDs, BLAs, etc.) and serve as a subject matter expert during regulatory agency meetings and/or inspections (FDA, EMA, etc.)
Qualification
Required
Master's degree or PhD in Engineering or a pertinent scientific discipline
Minimum 10+ years' experience in CMC operations, with thorough working knowledge of cGMPs and regulatory requirements
Experienced CMC leader in the biotechnology industry
SME in a broad range of purification technologies and methods
Extensive and proven experience with process development, process characterization and process validation of drug substance (microbial and mammalian platforms)
Proven track record of successful CMC project delivery in support of early-stage programs
Experience in early development including the transition of novel candidates from discovery through IND, Phase 1 and Phase 2 clinical trials
Proactively identify CMC risks and provide recommendations on mitigation
Identify, review and select external CROs, CDMOs and key consultants needed to allow smooth, efficient and cost-effective support for CMC programs
Excellent verbal and written communication skills
Self-motivated, delivery-oriented, assertive, able to inspire others, driven and hands-on with unquestionable integrity and the highest ethical standards
Experience representing technical operations (CMC) at FDA meetings and regulatory inspections
Experience writing relevant CMC sections of regulatory documents/submissions
Strong technical acumen, leadership, organizational planning, and project management skills
Effectiveness in leading, managing and/or influencing people
Successful delivery on cost and schedule for projects
Ability to sit for prolonged periods; reach with arms and hands; lift and move small objects; use hands to keyboard and perform other office related tasks including repetitive movement of the wrists, hands and/or fingers
Benefits
Stock equity awards
Participation in our Company’s discretionary annual bonus program
Full range of health and welfare insurance benefits
401(k) company match
Paid time off benefits
17 paid holidays in 2025
Company
Dynavax Technologies
Dynavax Technologies is a biopharmaceutical company discovering and developing novel products to prevent and treat infectious diseases.
Funding
Current Stage
Public CompanyTotal Funding
$1.58BKey Investors
Bill & Melinda Gates FoundationHercules CapitalNational Institute of Allergy and Infectious Diseases
2025-12-24Acquired
2025-03-06Post Ipo Debt· $225M
2021-05-11Post Ipo Debt· $200M
Recent News
2026-01-08
Company data provided by crunchbase